VenatoRx Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Malvern PA United States (2010)

Organization Overview

First Clinical Trial
2016
NCT02955459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Venatorx Pharmaceuticals, Inc. | VenatoRx Pharmaceuticals, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 1)

Communicable Diseases (Phase 3)

Infections (Phase 3)

Pyelonephritis (Phase 3)

Renal Insufficiency (Phase 1)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 13
  • # of Trial APIs: 8